Showing results (2001-2010 of 2,326) with videos related to

Sort By:
Pageof 233
Cancer Medicine|April 20, 2019
Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American WomenDelores J Grant, Ani Manichaikul, Anthony J Alberg, et al.
British Journal of Cancer|June 20, 2020
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis ConsortiumFilipe Correia Martins, Dominique-Laurent Couturier, Anna Paterson, et al.
Oncotarget|December 3, 2016
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaborationJennifer B Permuth, Brett Reid, Madalene Earp, et al.
British Journal of Cancer|November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium StudyAshley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2015
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association ConsortiumSharon E Johnatty, Jonathan P Tyrer, Siddhartha Kar, et al.
The Journal of Pathology. Clinical Research|August 1, 2018
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium studyPeter F Rambau, Robert A Vierkant, Maria P Intermaggio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous CarcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Nature Communications|May 13, 2020
Protein-altering germline mutations implicate novel genes related to lung cancer developmentXuemei Ji, Semanti Mukherjee, Maria Teresa Landi, et al.
American Journal of Human Genetics|June 13, 2023
Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestryBurcu F Darst, Jiayi Shen, Ravi K Madduri, et al.
Pageof 233